655.00
0.00
(0.00%)
At close: January 17 at 3:43:17 PM GMT+7
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,036,954,000.00
1,839,233,000.00
1,522,624,000.00
1,826,014,000.00
1,337,747,000.00
Cost of Revenue
1,478,244,000.00
1,319,778,000.00
1,138,576,000.00
1,039,720,000.00
777,850,000.00
Gross Profit
558,710,000.00
519,455,000.00
384,048,000.00
786,294,000.00
559,897,000.00
Operating Expense
349,251,000.00
321,499,000.00
273,655,000.00
234,270,000.00
173,379,000.00
Operating Income
209,459,000.00
197,956,000.00
110,393,000.00
552,024,000.00
386,518,000.00
Net Non Operating Interest Income Expense
-31,114,000.00
-30,042,000.00
-47,245,000.00
-55,064,000.00
-42,351,000.00
Pretax Income
316,636,000.00
267,578,000.00
70,475,000.00
465,944,000.00
378,676,000.00
Tax Provision
66,044,000.00
43,549,000.00
15,226,000.00
115,338,000.00
77,367,000.00
Net Income Common Stockholders
259,500,000.00
216,974,000.00
62,503,000.00
325,959,000.00
282,215,000.00
Diluted NI Available to Com Stockholders
259,500,000.00
216,974,000.00
62,503,000.00
325,959,000.00
282,215,000.00
Basic EPS
18.58
15.54
4.79
25.15
20.22
Diluted EPS
18.58
15.54
4.79
25.15
20.22
Basic Average Shares
13,959,422.30
13,959,422.30
13,043,468.53
13,959,422.30
13,959,422.30
Diluted Average Shares
13,959,422.30
13,959,422.30
13,043,468.53
13,959,422.30
13,959,422.30
Total Operating Income as Reported
214,919,000.00
204,419,000.00
111,805,000.00
555,835,000.00
388,090,000.00
Total Expenses
1,827,495,000.00
1,641,277,000.00
1,412,231,000.00
1,273,990,000.00
951,229,000.00
Net Income from Continuing & Discontinued Operation
259,500,000.00
216,974,000.00
62,503,000.00
325,959,000.00
282,215,000.00
Normalized Income
261,688,275.75
214,328,298.04
104,422,461.10
349,785,014.25
284,312,440.88
Interest Income
57,083,000.00
51,071,000.00
24,830,000.00
9,419,000.00
4,603,000.00
Interest Expense
88,197,000.00
81,113,000.00
72,075,000.00
64,483,000.00
46,954,000.00
Net Interest Income
-31,114,000.00
-30,042,000.00
-47,245,000.00
-55,064,000.00
-42,351,000.00
EBIT
404,833,000.00
348,691,000.00
142,550,000.00
530,427,000.00
425,630,000.00
EBITDA
410,925,000.00
352,155,000.00
142,881,000.00
530,839,000.00
426,190,000.00
Reconciled Cost of Revenue
1,478,244,000.00
1,319,778,000.00
1,138,576,000.00
1,039,720,000.00
777,850,000.00
Reconciled Depreciation
6,092,000.00
3,464,000.00
331,000.00
412,000.00
560,000.00
Net Income from Continuing Operation Net Minority Interest
259,500,000.00
216,974,000.00
62,503,000.00
325,959,000.00
282,215,000.00
Total Unusual Items Excluding Goodwill
-2,765,000.00
3,160,000.00
-47,154,000.00
-31,664,000.00
-2,636,000.00
Total Unusual Items
-2,765,000.00
3,160,000.00
-42,201,000.00
-31,664,000.00
-2,636,000.00
Normalized EBITDA
413,690,000.00
348,995,000.00
185,082,000.00
562,503,000.00
428,826,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-576,724.25
514,298.04
-10,187,538.90
-7,837,985.75
-538,559.12
12/31/2020 - 11/8/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SRAJ.JK PT Sejahteraraya Anugrahjaya Tbk
2,350.00
0.00%
MTMH.JK PT Murni Sadar Tbk
905.00
-1.09%
SAME.JK PT Sarana Meditama Metropolitan Tbk
260.00
0.00%
CARE.JK PT Metro Healthcare Indonesia Tbk
177.00
-3.80%
BMHS.JK PT Bundamedik Tbk
246.00
-0.81%
MIKA.JK PT Mitra Keluarga Karyasehat Tbk
2,350.00
+0.86%
SILO.JK PT Siloam International Hospitals Tbk
3,020.00
-1.31%
HEAL.JK PT Medikaloka Hermina Tbk
1,595.00
-2.45%